Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Drugs and Stimulation
The First People's Hospital of Lianyungang
Hearing Loss, Sudden
1 trial -
Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
The First People's Hospital of Lianyungang
Diabetes
1 trial -
Dynamometric tension assessment
The First People's Hospital of Lianyungang
Incisional Hernia
1 trial -
EAA
United Therapeutics Europe Ltd
Military Operational Stress Reaction
1 trial -
EAA+W & Carbohydrate
United Therapeutics Europe Ltd
Energy Deficit
1 trial -
EPCs plus PTA
The First People's Hospital of Lianyungang
Diabetic Foot
1 trial -
ERA
NORTHWEST BIOTHERAPEUTICS INC
Infertility, Female
1 trial -
ESC 0/1 hour troponin pathway
NORTHWEST BIOTHERAPEUTICS INC
Acute Coronary Syndrome
1 trial -
ETEC strain B7A (O148:H28 CS6+ LT+ST+) (Lot 0481) in Buffer
United Therapeutics Europe Ltd
Healthy Volunteer
1 trial -
EVM18001 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
System Lupus Erythematosus(SLE)
1 trial -
Early auto-mode
Century Therapeutics
Diabetes Mellitus Type 1 Pre-Existing
1 trial -
EchoGo
United Therapeutics Europe Ltd
Coronary Heart Disease
1 trial -
Efgartigimod + Telitacicept (1-week interval) group
The First People's Hospital of Lianyungang
Myasthenia Gravis
1 trial -
EmbryoGlue® (laboratory culture medium)
United Therapeutics Europe Ltd
Infertility
1 trial -
Energy Balance
United Therapeutics Europe Ltd
Inflammation
1 trial -
Entecavir 0.5 mg
The First People's Hospital of Lianyungang
Hepatitis B
1 trial -
Envita Stories Methodology in Long-term care Centres for old adults
Gain Therapeutics
Long-term Care Centres for Old Adults Users
1 trial -
Ergocalciferol
United Therapeutics Europe Ltd
Chronic Kidney Disease
1 trial -
Escitalopram Oxalate Tablets
The First People's Hospital of Lianyungang
Major Depressive Disorder
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial -
Esketamine
The First People's Hospital of Lianyungang
Post Induction Hypotension
1 trial -
Esketamine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anesthesia
1 trial -
Esketamine at low dose
The First People's Hospital of Lianyungang
Insomnia
1 trial -
Esketamine nasal spray
United Therapeutics Europe Ltd
Depression
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources